Is Range Cancer Therapeutics ETF halal to invest in?

As of September 2026, Range Cancer Therapeutics ETF CNCR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Range Cancer Therapeutics ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Range Cancer Therapeutics ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Range Cancer Therapeutics ETF updated?

The Shariah compliance status of Range Cancer Therapeutics ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Range Cancer Therapeutics ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Range Cancer Therapeutics ETF?

You can check the latest Shariah compliance status of Range Cancer Therapeutics ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Range Cancer Therapeutics ETF CNCR

CNCR Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Range Cancer Therapeutics ETF is classified as not halal.

NOT HALAL

Is Range Cancer Therapeutics ETF Halal?

Shariah Compliance Analysis of CNCR ETF

US Equity Health Care

No. As of September 2026, Range Cancer Therapeutics ETF (CNCR) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Range Cancer Therapeutics ETF does not pass Musaffa's business and financial screening criteria.

CNCR was created on 2015-10-13 by Range. The fund's investment portfolio concentrates primarily on health care equity. CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products.

Range Cancer Therapeutics ETF (CNCR) Chart

Key Statistics of Range Cancer Therapeutics ETF (CNCR)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
95.53%
Other
4.29%
Materials
0.18%

FAQ's for Range Cancer Therapeutics ETF (CNCR)

As of September 2026, Range Cancer Therapeutics ETF CNCR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Range Cancer Therapeutics ETF using these criteria to determine its compliance status.
The Shariah compliance status of Range Cancer Therapeutics ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Range Cancer Therapeutics ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.